1

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma

slmxxz5yz2k2
IntroductionEpendymomas (EPN) are the third most common malignant brain cancer in children. Treatment strategies for pediatric EPN have remained unchanged over recent decades. with 10-year survival rates stagnating at just 67% for children aged 0-14 years. Moreover. https://www.hacklinkci.com/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story